Pay in 4 interest-free payments of $31.24 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Landesman Y
a macrocyclic lactone
Smiles: C[C@@H](NC(=O)[C@H](O)C1=CC(F)=CC(F)=C1)C(=O)N[C@@H]1C(=O)N(C)C2=CC=CC=C2C2=CC=CC=C21
PubMed PMID: 25449811
PubMed PMID: 26354274
Miglustat Hydrochloride 240551 Landesman YMiglustat, also known as OGT 918 and NB DNJ, is a drug developed by Actelion and is used primarily to treat Type I Gaucher disease (GD1). Miglustat inhibits glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids (it forms glucosylceramide and accumulates within the macrophages). Miglustat is used to treat adults with mild to moderate Type I Gaucher disease and it is the first treatment to be approved for patients
US$ 75.00
US$ 44.00
US$ 65.00
US$ 35.00
US$ 52.00
US$ 95.00
US$ 49.90
US$ 32.00
US$ 40.00
US$ 124.00
US$ 43.90
US$ 28.00
US$ 24.99
US$ 62.00
US$ 35.00
US$ 75.00
US$ 49.90
US$ 25.00